CHF6523

· Chiesi Farmaceutici S.p.A.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CHF6523, covering 2025-02-13 to 2025-02-13. Get the full timeline:

Most recent: Clinical Trial Update: Investigate the Safety, Tolerability and Pharmacokinetics of CHF6523 in Healthy and in COPD Subjects [Phase 1]